Skip NavigationSkip to Content
Return Return to Search Results

Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors

  1. Author:
    Mechanic, L. E.
    Bowman, E. D.
    Welsh, J. A.
    Khan, M. A.
    Hagiwara, N.
    Enewold, L.
    Shields, P. G.
    Burdette, L.
    Chanock, S.
    Harris, C. C.

  2. Author Address

    NCI, Human Carcinogenesis Lab, NIH, Ctr Canc Res, Bethesda, MD 20892 USA. Nippon Med Coll Hosp, Dept Surg 1, Tokyo, Japan. Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA. NCI, Frederick Canc Res & Dev Ctr, Ctr Adv Technol,Sci Applicat Int Corp Frederick, Intramural Res Support Program, Frederick, MD USA. NCI, Pediat Oncol Branch, Ctr Canc Res, Rockville, MD USA. NCI, Dept Canc Epidemiol & Genet, Rockville, MD USA.;Harris, CC, NCI, Human Carcinogenesis Lab, NIH, Ctr Canc Res, Room 3068,Bldg 37,37 Convent Dr, Bethesda, MD 20892 USA.;Curtis_Harris@nih.gov
    1. Year: 2007
    2. Date: Feb
  2. Journal: Cancer Epidemiology Biomarkers & Prevention
    1. 16
    2. 2
    3. Pages: 214-222
  4. Type of Article: Article
  5. ISSN: 1055-9965
  1. Abstract:

    Lung cancer is primarily caused by tobacco smoking, but susceptibility is likely modified by common genetic variation. In response to many forms of cellular stress, including DNA damage, the p53 protein functions to induce cell cycle arrest, DNA repair, senescence, or apoptosis. We hypothesized that common TP53 haplotypes modulate pathways of lung carcinogenesis and lung cancer susceptibility or prognosis. To investigate our hypothesis, 14 polymorphisms in TP53, including haplotype tagging and coding single nucleotide polymorphisms, were genotyped in two studies from the greater Baltimore, Maryland area. One study is a case-control study and the second is a case-only study for which TP53 mutational spectra data are available. African Americans with Pro-T-A-G-G haplotypes of the combined TP53 polymorphisms TP53_01 (rs1042522), TP53_65 (rs9895829), TP53_66 (rs2909430), TP53_16 (rs1625895), and TP53_11 (rs12951053) had both an increased risk for lung cancer (odds ratio, 2.32; 95% confidence interval, 1.18-4.57) and a worsened lung cancer prognosis (hazards ratio, 2.38; 95% confidence interval, 1.38-4.10) compared with those with Arg-T-A-G-T haplotypes. No associations of TP53 polymorphisms with lung cancer were observed in Caucasians. In the case-only study, several polymorphisms in TP53 and TP53 haplotypes, overlapping regions of TP53 associated with risk and prognosis in African Americans, were associated with increased odds of somatic TP53 mutation in lung tumors in Caucasians. In conclusion, common genetic variation in TP53 could modulate lung cancer pathways, as suggested by the association with lung cancer in African Americans and somatic TP53 mutation frequency in lung tumors.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1158/1055-9965.epi-06-0790
  3. View record in Web of Science®
  4. WOS: 000244293400008

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel